doxifluridine has been researched along with Ovarian Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akimoto, T; Hasegawa, K; Kishimoto, Y; Morimoto, Y; Sawai, T | 1 |
| Deguchi, Y; Kamimura, K; Kaneko, I; Kii, E; Murata, T; Nonogaki, H; Tanaka, T; Tsubono, M; Yasumizu, R | 1 |
| Etoh, T; Maeda, Y; Matoba, N; Nagata, T; Niiyama, H; Yoshida, J | 1 |
| Collins, WP; Farzaneh, F; Hata, K; Miyazaki, K; Stevenson, DP | 1 |
| Fujii, H; Kumagai, K; Terai, Y; Ueda, M; Ueki, K; Ueki, M; Yanagihara, T; Yoshizawa, K | 1 |
| Ikeda, M; Noda, K; Ochiai, K; Saito, Y; Sato, A; Suzuki, M; Takada, M; Terashima, Y; Yajima, A; Yoshida, K | 1 |
| Neijt, JP; ten Bokkel Huinink, WW; van der Burg, ME; van Oosterom, AT; Vermorken, JB; Willemse, PH | 1 |
| Adachi, S; Akaza, H; Ishitsuka, H; Kanazawa, K; Miwa, M; Nitta, K; Sekiguchi, F; Tokita, H | 1 |
| Hasegawa, K; Ikeda, M; Kinugasa, M; Kobashi, Y; Noda, K; Odagiri, H; Ohiwa, T; Sekiba, K; Takeuchi, K; Watanabe, Y | 1 |
| de Bruijn, EA; Pinedo, HM; Reeuwijk, HJ; Tjaden, UR; van Oosterom, AT | 1 |
1 review(s) available for doxifluridine and Ovarian Neoplasms
| Article | Year |
|---|---|
[Peritoneal dissemination of cecal cancer disappearing in a patient taking 5'-DFUR for 3 years].
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Cecal Neoplasms; Female; Floxuridine; Humans; Middle Aged; Neoplasms, Second Primary; Ovarian Neoplasms; Peritoneal Neoplasms; Remission Induction | 1994 |
9 other study(ies) available for doxifluridine and Ovarian Neoplasms
| Article | Year |
|---|---|
[Significance of tissue thymidine phosphorylase and dihydropyrimidine dehydrogenase activities in ovarian cancer].
Topics: 5'-Nucleotidase; Adenocarcinoma, Scirrhous; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Female; Floxuridine; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms; Survival Rate | 2004 |
[Weekly paclitaxel administration and intraabdominal CBDCA injection possibly beneficial treatment for recurrent breast cancer associated with metastatic ovarian cancer and peritoneal dissemination after operation--a case report].
Topics: Adenocarcinoma, Scirrhous; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Drug Administration Schedule; Female; Floxuridine; Humans; Hysterotomy; Infusions, Intravenous; Injections, Intraperitoneal; Middle Aged; Nitriles; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Triazoles | 2005 |
Thymidine phosphorylase activity and prodrug effects in a three-dimensional model of angiogenesis: implications for the treatment of ovarian cancer.
Topics: Adult; Animals; Antineoplastic Agents; Female; Floxuridine; Humans; Isomerism; Microcirculation; Neovascularization, Pathologic; Ovarian Neoplasms; Prodrugs; Rats; Rats, Wistar; Recombinant Proteins; Thymidine Phosphorylase; Tumor Cells, Cultured | 1998 |
Effects of sex steroids and growth factors on invasive activity and 5'-deoxy-5-fluorouridine sensitivity in ovarian adenocarcinoma OMC-3 cells.
Topics: Basement Membrane; Cell Division; Cell Movement; Collagenases; Culture Media, Conditioned; Cystadenocarcinoma, Mucinous; Drug Resistance, Neoplasm; Enzyme Induction; Epidermal Growth Factor; ErbB Receptors; Estradiol; Female; Fibronectins; Floxuridine; Humans; Matrix Metalloproteinase 3; Neoplasm Invasiveness; Neoplasm Proteins; Ovarian Neoplasms; Prodrugs; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Thymidine Phosphorylase; Transforming Growth Factor alpha; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1998 |
[Phase II study of 5'-DFUR in uterine cervical cancer and ovarian cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Female; Floxuridine; Humans; Middle Aged; Ovarian Neoplasms; Uterine Cervical Neoplasms | 1991 |
Phase II clinical trial of doxifluridine in patients with advanced ovarian cancer.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Floxuridine; Humans; Kidney; Middle Aged; Ovarian Neoplasms | 1991 |
[Comparative studies on the antitumor activity of fluorinated pyrimidine derivatives against human bladder, cervical and ovarian cancer xenografts in nude mice].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Floxuridine; Fluorouracil; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 1991 |
[Investigation of 5-fluorouracil (5-FU) levels and pyrimidine nucleoside phosphorylase activities in the tissues from patients with uterine cervical and ovarian cancers after oral administration of 5'-DFUR].
Topics: Administration, Oral; Antineoplastic Agents; Female; Floxuridine; Fluorouracil; Humans; Lymph Nodes; Ovarian Neoplasms; Ovary; Pentosyltransferases; Pyrimidine Phosphorylases; Uterine Cervical Neoplasms; Uterus | 1991 |
Pharmacology of 5'-deoxy-5-fluorouridine in patients with resistant ovarian cancer.
Topics: Adult; Aged; Antineoplastic Agents; Female; Floxuridine; Fluorouracil; Humans; Kinetics; Middle Aged; Ovarian Neoplasms | 1985 |